
Syncona Ltd - London-based investor in life science companies - Invests USD24.5 million in ophthalmic gene therapy company Beacon Therapeutics' USD75 ...


(Alliance News) - Syncona Ltd on Thursday reported a fall in its net asset value but said it is well-positioned to deliver value as market conditions ...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


Syncona Ltd - London-based investor in life science companies - Sets out results of its strategy review, proposing focus on realisations of mature pri...


(Clarifying that Brent oil was trading higher early Tuesday, not lower.)


(Alliance News) - Stock prices in London opened higher on Tuesday as investors digested fresh UK borrowing figures showing the government's finances r...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Alliance News) - Syncona Ltd on Thursday said its net asset value increased during the first quarter of its financial year, citing strong clinical ex...